| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 726798 | 1181264010 | ALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 180 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264010/1181264010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264010/1181264010_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 726758 | 1181264011 | ALUNBRIG 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264011/1181264011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264011/1181264011_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 726797 | 1181264008 | ALUNBRIG 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 90 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264008/1181264008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264008/1181264008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 726799 | 1181264012 | ALUNBRIG 90MG + 180MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 90MG + 180MG COMPRIMIDOS RECUBIERTOS CON PELICULA Envase de inicio: 28 comprimidos (7 x 90 mg + 21 x 180 mg) | 90 mg + 180 mg | 5 | 28 | 10 | Envase de inicio: 28 comprimidos (7 x 90 mg + 21 x 180 mg) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264012/1181264012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264012/1181264012_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 720666 | 82857 | ALUTARD SQ APIS MELLIFERA 100.000 SQ-U/ML SUSPENSION INYECTABLE | ALUTARD SQ APIS MELLIFERA 100.000 SQ-U/ML SUSPENSION INYECTABLE, 1 vial de 5 ml | 100.000 SQ-U/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82857/82857_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82857/82857_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15 | ALK ABELLO S.A. | 2018-03-23 | 1 | 1 | 1 | 2018-03-23 | 2018-03-23 | 1 | 2021-02-10 | View Edit Delete | ||||||||||||
| 720665 | 82856 | ALUTARD SQ APIS MELLIFERA ENVASE DE INICIO (100 SQ-U/ML, 1.000 SQ-U/ML, 10.000 SQ-U/ML Y 100.000 SQ-U/ML) SUSPENSION INYECTABLE | ALUTARD SQ APIS MELLIFERA ENVASE DE INICIO (100 SQ-U/ML, 1.000 SQ-U/ML, 10.000 SQ-U/ML Y 100.000 SQ-U/ML) SUSPENSION INYECTABLE, 4 viales de 5 ml (1+1+1+1) | 100 + 1.000 + 10.000 + 100.000 SQ-U/ml inyectable 5 ml | 45 | 4 | 34 | 4 viales de 5 ml (1+1+1+1) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82856/82856_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82856/82856_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15 | ALK ABELLO S.A. | 2018-03-23 | 1 | 1 | 1 | 2018-03-23 | 2018-03-23 | 1 | 2021-02-10 | View Edit Delete | ||||||||||||
| 720668 | 82859 | ALUTARD SQ VESPULA SPP 100.000 SQ-U/ML SUSPENSION INYECTABLE | ALUTARD SQ VESPULA SPP. 100.000 SQ-U/ML SUSPENSION INYECTABLE, 1 vial de 5 ml | 100.000 SQ-U/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82859/82859_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82859/82859_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15 | ALK ABELLO S.A. | 2018-03-23 | 1 | 1 | 1 | 2018-03-23 | 2018-03-23 | 1 | 2021-02-10 | View Edit Delete | ||||||||||||
| 720667 | 82858 | ALUTARD SQ VESPULA SPP ENVASE DE INICIO (100 SQ-U/ML, 1000 SQ-U/ML, 10.000 SQ-U/ML Y 100.000 SQ-U/ML) SUSPENSION INYECTABLE | ALUTARD SQ VESPULA SPP ENVASE DE INICIO (100 SQ-U/ML, 1000 SQ-U/ML, 10.000 SQ-U/ML Y 100.000 SQ-U/ML) SUSPENSION INYECTABLE, 4 viales de 5 ml (1+1+1+1) | 100 + 1.000 + 10.000 + 100.000 SQ-U/ml inyectable 5 ml | 45 | 4 | 34 | 4 viales de 5 ml (1+1+1+1) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82858/82858_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82858/82858_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15 | ALK ABELLO S.A. | 2018-03-23 | 1 | 1 | 1 | 2018-03-23 | 2018-03-23 | 1 | 2021-02-10 | View Edit Delete | ||||||||||||
| 763857 | 70372 | ALVESCO 160 microgramos/INHALACION SOLUCION PARA INHALACION EN ENVASE A PRESION | ALVESCO 160 microgramos/INHALACION SOLUCION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 dosis | 160 microgramos/dosis | 34 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70372/70372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70372/70372_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34767 | ZENTIVA SPAIN S.L. | 2009-03-30 | 1 | 1 | 1 | 2009-03-30 | 2023-11-29 | 1 | 2024-08-28 | View Edit Delete | ||||||||||||
| 768306 | 1251943002 | ALYFTREK 125 MG/50 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALYFTREK 125 MG/50 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 125 mg/50 mg/10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251943002/1251943002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251943002/1251943002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 49010 | VERTEX PHARMACEUTICALS (SPAIN) S.L. | 2025-08-13 | 1 | 1 | 1 | 2025-08-14 | 2025-08-13 | 1 | 2026-05-13 | View Edit Delete | ||||||||||||
| 768307 | 1251943001 | ALYFTREK 50 MG/20 MG/4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALYFTREK 50 MG/20 MG/4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 comprimidos | 50 mg/20 mg/4 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251943001/1251943001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251943001/1251943001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 49010 | VERTEX PHARMACEUTICALS (SPAIN) S.L. | 2025-08-13 | 1 | 1 | 1 | 2025-08-14 | 2025-08-13 | 1 | 2026-05-13 | View Edit Delete | ||||||||||||
| 730998 | 1201509001 | ALYMSYS 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ALYMSYS 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201509001/1201509001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201509001/1201509001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36466 | CIPLA EUROPE NV SUCURSAL EN ESPANA | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2021-08-17 | View Edit Delete | ||||||||||||
| 730999 | 1201509001 | ALYMSYS 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ALYMSYS 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 25 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201509001/1201509001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201509001/1201509001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36466 | CIPLA EUROPE NV SUCURSAL EN ESPANA | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2021-08-17 | View Edit Delete | ||||||||||||
| 732421 | 85558 | ALZERTA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG | ALZERTA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG, 60 (2 x 30) parches transdérmicos | 13,3 mg/24 h | 35 | 60 | 28 | 60 (2 x 30) parches transdérmicos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85558/85558_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85558/85558_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2020-12-15 | 1 | 1 | 1 | 2020-12-15 | 2021-12-07 | 0 | 2022-02-14 | View Edit Delete | ||||||||||||
| 729742 | 85556 | ALZERTA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | ALZERTA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 60 (2 x 30) parches transdérmicos (Sobre Papel/PET/Al/LasPold) | 4,6 mg/24 h | 35 | 60 | 28 | 60 (2 x 30) parches transdérmicos (Sobre Papel/PET/Al/LasPold) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85556/85556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85556/85556_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2020-12-15 | 1 | 1 | 1 | 2020-12-15 | 2020-12-15 | 0 | 2021-04-14 | View Edit Delete | ||||||||||||
| 730012 | 85556 | ALZERTA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | ALZERTA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 30 parches transdérmicos (Sobre Papel/PET/Al/LasPold) | 4,6 mg/24 h | 35 | 30 | 28 | 30 parches transdérmicos (Sobre Papel/PET/Al/LasPold) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85556/85556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85556/85556_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2020-12-15 | 1 | 1 | 1 | 2020-12-15 | 2020-12-15 | 0 | 2021-04-14 | View Edit Delete | ||||||||||||
| 729744 | 85557 | ALZERTA 9,5 MG/24 H PARCHES TRANSDERMICOS EFG | ALZERTA 9,5 MG/24 H PARCHES TRANSDERMICOS EFG, 60 (2 x 30) parches transdérmicos (Sobre Papel/PET/Al/LasPolD) | 9,5 mg/24 h | 35 | 60 | 28 | 60 (2 x 30) parches transdérmicos (Sobre Papel/PET/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85557/85557_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85557/85557_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2020-12-15 | 1 | 1 | 1 | 2020-12-15 | 2020-12-15 | 0 | 2021-04-14 | View Edit Delete | ||||||||||||
| 758841 | 86148 | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS, 8 parches (papel / PET / PE / Al/ LasPolD | 4,6 mg/24 h | 74 | 8 | 28 | 8 parches (papel / PET / PE / Al/ LasPolD | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86148/86148_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86148/86148_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2021-08-10 | 1 | 1 | 1 | 2021-08-11 | 2022-10-25 | 0 | 2024-01-10 | View Edit Delete | ||||||||||||
| 758842 | 86148 | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS, 16 parches (papel / PET / PE / Al/ LasPolD | 4,6 mg/24 h | 74 | 16 | 28 | 16 parches (papel / PET / PE / Al/ LasPolD | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86148/86148_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86148/86148_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2021-08-10 | 1 | 1 | 1 | 2021-08-11 | 2022-10-25 | 0 | 2024-02-20 | View Edit Delete | ||||||||||||
| 759286 | 86149 | ALZERTA DOS POR SEMANA 9,5 MG/24 H PARCHES TRANSDERMICOS | ALZERTA DOS POR SEMANA 9,5 MG/24 H PARCHES TRANSDERMICOS, 16 parches | 9,5 mg/24 h | 74 | 16 | 28 | 16 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86149/86149_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86149/86149_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2021-08-10 | 1 | 1 | 1 | 2021-08-11 | 2022-11-22 | 0 | 2023-11-13 | View Edit Delete |
Page 50 of 1036, showing 20 records out of 20708 total, starting on record 981, ending on 1000